Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC)

NCT01409499 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Hepatectomy
Hepatocellular Carcinoma
Sorafenib

Interventions

PROCEDURE: hepatic resection
PROCEDURE: transcatheter hepatic arterial chemoembolization
DRUG: sorafenib

Sponsor

Sun Yat-sen University